Close

Intuitive Surgical (ISRG) Tops Q3 EPS by 101c

October 20, 2015 4:09 PM EDT

Intuitive Surgical (NASDAQ: ISRG) reported Q3 EPS of $5.24, $1.01 better than the analyst estimate of $4.23. Revenue for the quarter came in at $590 million versus the consensus estimate of $580.37 million.

  • Worldwide da Vinci procedures grew approximately 15% over the third quarter of 2014, driven primarily by growth in U.S. general surgery procedures and broad-based procedure growth in Asia and other international markets.
  • The Company shipped 117 da Vinci Surgical Systems, compared with 111 in the third quarter of 2014 and 118 in the second quarter of 2015.
  • Non-GAAP* revenue of $590 million for the quarter grew approximately 10% compared with $534 million for the third quarter of 2014.
  • Third quarter 2015 non-GAAP* net income was $199 million, or $5.24 per diluted share, compared with $145 million, or $3.92 per diluted share, for the third quarter of 2014. The Company's third quarter 2015 income tax expense benefited by approximately $29 million, or $0.77 per diluted share, relating to certain tax benefits recorded in the quarter.
  • During the third quarter 2015 the Company filed for FDA 510(k) clearances in the U.S. for Single-Site instruments and 30mm EndoWrist stapler products for the da Vinci XiSurgical System.

For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Hot Earnings

Related Entities

Earnings